Evox Therapeutics Ltd

Evox Therapeutics is a privately held, Oxford-based biotechnology company at the forefront of developing exosome therapeutics. Their focus is on improving the natural delivery capabilities of exosomes, creating an entirely new class of therapeutics that can address unmet needs across various disease areas, particularly rare and severe diseases. Evox has built a comprehensive intellectual property estate and has secured partnerships with leading organizations like Eli Lilly and Takeda to advance its exosome-based pipeline.

Evox's proprietary DeliverEX® platform enables the loading of exosomes with diverse drug cargos, including genetic medicines, enzymes, and antibodies. Their technology leverages the unique tissue targeting properties of exosomes, overcoming challenges of conventional delivery methods. Evox's mission is to positively impact human health by creating novel exosome-based therapeutics that provide impactful treatment options for patients and their families.

Evox Therapeutics offers a variety of benefits to its employees, including 25 days of holiday plus bank holidays, private medical cover for new and pre-existing conditions, life assurance, and a pension plan with an employer contribution of 5%. While specific details on job flexibility are not provided, the company's focus on creating a supportive and challenging environment suggests a degree of flexibility may be available, particularly in terms of remote work options.

Evox Therapeutics offers a competitive benefits package to its employees, including private medical coverage for both new and pre-existing conditions, life assurance at four times the base salary, 25 days of paid holiday plus bank holidays, a pension plan with a 5% employer contribution and a 5% minimum employee contribution (with the option to contribute more), and a discretionary bonus based on both corporate and personal performance.

Evox Therapeutics, an Oxford-based biotechnology company, is dedicated to revolutionizing medicine by harnessing the natural delivery capabilities of exosomes, tiny vesicles that act as communication messengers within the body. Their mission is to develop a new class of therapeutics that leverage exosomes' unique ability to deliver drugs to hard-to-reach organs and tissues, addressing the unmet needs of patients with severe and rare diseases. By engineering exosomes to carry and deliver therapeutic payloads, Evox aims to improve treatment options for conditions that are currently difficult to target with conventional drug delivery methods.

Evox Therapeutics cultivates a culture that values open communication, collaboration, and innovation. They prioritize a supportive and challenging environment where employees are empowered to contribute their ideas and advance their careers. Their commitment to diversity fosters a welcoming atmosphere where individuals can thrive and make a real difference in the lives of patients.

Evox Therapeutics is committed to fostering a diverse and inclusive workplace. They believe in creating an open and transparent environment where collaboration and innovation are encouraged. They actively work to build multidisciplinary teams with a variety of backgrounds and perspectives to ensure that their mission to improve the lives of patients suffering from severe diseases is realized.